低钙透析对低甲状旁腺激素血液透析患者矿物质及骨代谢的影响

doi:10.3969/j.issn.1006-7795.2016.02.023

摘要/Abstract

摘要： 目的低钙透析对低甲状旁腺激素血液透析患者甲状旁腺激素及骨代谢的影响。方法选取70例血清全段甲状旁腺激素(intact parathyroid,iPTH)<100 pg/mL的维持性血液透析患者。应用1.25 mmol/L钙浓度透析液进行血液透析治疗,随访1年。常规检测生化指标——血钙、血磷、血清碱性磷酸酶(alkaline phosphatase,ALP),化学发光法检测iPTH、骨钙素(osteocalcin, OC)、I型前胶原氨基末端前肽(procollagen type I amino-terminal propeptide, PINP)、β胶原蛋白(β-crosslaps, β-CTX),观察患者应用1.25 mmol/L钙浓度透析液前及应用后1、3、6、12个月时血钙、血磷、ALP、iPTH变化以及OC、PINP、β-CTX等骨代谢指标的变化。结果 1)血清iPTH浓度于应用1.25 mmol/L钙浓度透析液3个月后显著升高(P<0.001);2)更换透析液后各时间点与更换前比较,血清OC浓度、PINP浓度及β-CTX浓度于更换1个月后显著升高,差异有统计学意义(P<0.001);3)OC浓度变化与年龄呈负相关(r=-0.816,P<0.001)、与基线iPTH浓度呈正相关(r=0.673,P=0.037);β-CTX浓度变化与年龄呈负相关(r=-0.718,P<0.001)、与基线iPTH浓度吴正相关(r=0.651,P=0.020);4)更换透析液前基线血清iPTH浓度(P<0.001)、糖尿病史(P=0.012)是iPTH改善的独立影响因素。结论低钙透析可以改善低甲状旁腺激素患者iPTH浓度,升高OC、PINP及β-CTX浓度,增加骨代谢,是治疗低转运骨病的有效方法。

关键词: 骨代谢, 低钙透析, 低甲状旁腺激素, 血液透析

Abstract: Objective To observe the effect of dialysate with lowering calcium concentration on mineral metabolism and bone turnover in patients with low level of parathyroid hormone on hemodialysis.Methods Total 70 patients with iPTH<100 pg/mL were treated with DCa-1.25mmol/l dialysate for 1 year. Serum calcium, phosphorus, alkaline phosphatase(ALP) levels were determined by standard method. Their levels of serum intact parathyroid (iPTH), osteocalcin (OC), procollagen type I amino-terminal propeptide (PINP), β-crosslaps (β-CTX) were measured by Chemiluminescence. iPTH, OC, PINP, β-CTX, serum calcium, phosphorus, ALP were measured before and 1, 3, 6, 12 months after the change of dialysate. Results After lowering D-Ca, serum iPTH levels progressively increased at 3 months(P<0.001), and serum OC, PINP, β-CTX levels increased at 1 months(P<0.001). In correlation analyses, the changes in OC and β-CTX correlated positively with baseline iPTH (OC:r=0.673, P=0.037;β-CTX:r=0.651, P=0.020), and correlated negatively with age (OC:r=-0.816, P<0.001;β-CTX:r=-0.718, P<0.001). In Logistic regression analysis, baseline iPTH, diabetes were independent factors of the improvement of iPTH level. Conclusion Dialysate with lowering calcium concentration can improve PTH levels and stimulate bone metabolism.

Key words: bone metabolism, low calcium dialysate, low parathyroid hormone, hemodialysis

中图分类号:

R692

马丽洁, 李忠心, 刘婧, 赵素梅. 低钙透析对低甲状旁腺激素血液透析患者矿物质及骨代谢的影响[J]. 首都医科大学学报, 2016, 37(2): 228-232.

Ma Lijie, Li Zhongxin, Liu Jing, Zhao Sumei. Effects of lowering dialysate calcium concentration on mineral metabolism and bone turnover in patients with low level of parathyroid hormone on hemodialysis[J]. Journal of Capital Medical University, 2016, 37(2): 228-232.

参考文献

[1] Malluche H H,Mawad H,Monier-Faugere M C.The importance of bone health in end-stage renal disease:out of the frying pan,into the fire?[J]. Nephrol Dial Transplant,2004,19 Suppl 1:i9-13.
[2] Jeloka T, Mali M, Jhamnani A, et al.Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients?[J]. J Assoc Physicians India,2012,60:102-105.
[3] Iwasaki Y, Yamato H, Nii-Kono T,et al.Insufficiency of PTH action on bone in uremia[J]. Kidney Int suppl,2006 (102):S34-S36.
[4] Moe S,Drueke T,Cunningham J,et al.Definition,evaluation,and classification of renal osteodystrophy:a position statement from Kidney Disease:Improving Global Outcomes(KDIGO)[J].Kidney Int,2006,69(11):1945-1953.
[5] Salusky I B, Goodman W G. Adynamic renal osteodystrophy:is there a problem?[J].J Am Soc Nephrol,2001,12(9):1978-1985.
[6] 中华医学会肾脏病学分会.慢性肾脏病-矿物质和骨异常诊治指导[J]. 中华肾脏病杂志,2014,30(Z1):20-30.
[7] Rhee H,Song S H,Kwak I S,et al. Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients[J].Clin Exp Nephrol,2012,16(3):433-441.
[8] Bosticardo G,Malberti F,Basile C,et al.Optimizing the dialysate calcium concentration in bicarbonate haemodialysis[J].Nephrol Dial Transplant,2012,27(6):2489-2496.
[9] Frazao J M,Martins P.Adynamic bone disease:clinical and therapeutic implications[J].Curr Opin Nephrol Hypertens,2009,18 (4):303-307.
[10] Spasovski G,Gelev S,Masin-Spasovska J,et al.Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium[J].Bone,2007,41(4):698-703.
[11] Barreto F C,Barreto D V,Moyses R M,et al. K/DOQI recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients[J].Kidney Int,2008,73(6):771-777.
[12] Yoshimura N, Muraki S, Oka H, et al. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women:10-year follow-up of the Taiji cohort[J]. Mod Rheumatol,2011,21(6):608-620.
[13] 钱莹,陈晓农,朱萍,等. 25例高转换型肾性骨病的骨组织学研究[J]. 中国血液净化,2013,12(10):535-536.
[14] Delmas PD.Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs[J]. Osteoporos Int,2000, 11 Suppl 6:S66-S76.
[15] Hamano T, Oseto S, Fujii N, et al. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients[J]. Bone,2005, 36(5):909-916.
[16] 顾波.终末期肾病低转运骨病的研究新进展[J]. 国际泌尿系统杂志,2011,31(5)693-695.
[17] 万丽娟, 李春霖,龚燕平,等.代谢因素对老年男性骨转换生化标志物的影响分析[J]. 临床误诊误治,2015,28(5):93-96.
[18] 邹建洲,刘中华,沈波,等. 低钙透析对低甲状旁腺激素血症血液透析患者骨盐代谢的影响[J]. 中华肾脏病杂志,2010,26(7):562-563.